CD19, CD19 molecule, 930

N. diseases: 365; N. variants: 5
Disease: Diffuse large B-cell lymphoma recurrent ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0855111
Disease: Diffuse large B-cell lymphoma recurrent
Diffuse large B-cell lymphoma recurrent 		0.020 Biomarker disease BEFREE Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma. 30622321 2019
CUI: C0855111
Disease: Diffuse large B-cell lymphoma recurrent
Diffuse large B-cell lymphoma recurrent 		0.020 GeneticVariation disease BEFREE To address this gap, we report the case of a 68-year-old woman with refractory/relapsed diffuse large B cell lymphoma (DLBCL), treated with tisagenlecleucel (anti-CD19), with a CD137 costimulatory domain (4-1BB) on an investigational new drug application (#16944). 30572564 2018